Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study

詳細情報 詳細情報について

• CRID

  1360298760968379392

• DOI

  10.1016/j.clml.2021.04.012

• ISSN

  21522650

• Web Site

  https://api.elsevier.com/content/article/PII:S2152265021001567?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S2152265021001567?httpAccept=text/plain

• データソース種別

  • Crossref